GLRX and neoplasm: Notably, increased expression of several ROS hallmark genes involved in antioxidant response—Idh1, Nfe2l2 (NRF2), and Glrx—were validated by reverse transcription quantitative polymerase chain reaction (RT-qPCR) in both tumor-derived cell lines and whole tumor lysates (Fig. 2, D and E).